In addition, BMS-754807 treatment induced phosphorylation of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2), which contributed to BMS-754807-induced p70S6K1 activation for survival in colon cancer cells. This evidence concerns the gene MAP2K1 and colonic neoplasm.